However, in recent years, the dark side of NRF2 has emerged and growing evidence suggests that NRF2 constitutive upregulation is associated with cancer development and progression and contributes to both intrinsic and acquired chemo- and radio-resistance [26]. This evidence concerns the gene NFE2L2 and cancer.